119 related articles for article (PubMed ID: 9793268)
1. Pulmonary multinodular relapse of non-Hodgkin's lymphoma.
Arguiñano JM; Pérez Equiza E; Gorosquieta AM
Haematologica; 1998 Aug; 83(8):759-60. PubMed ID: 9793268
[TBL] [Abstract][Full Text] [Related]
2. [Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma].
Hirose A; Yamane T; Nakajima Y; Manabe M; Kanashima H; Hagihara K; Sakamoto E; Nakamae M; Terada Y; Kosaka S; Aoyama Y; Sakamoto C; Kumura T; Koh KR; Hirai M; Ohta K; Nakao Y; Mugitani A; Teshima H; Hino M
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2059-64. PubMed ID: 16352929
[TBL] [Abstract][Full Text] [Related]
3. Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma.
Gabarre J; Leblond V; Sutton L; Azar N; Jouan M; Boccaccio C; Gonzalez H; Charlotte F; Gentilini M; Binet JL
Bone Marrow Transplant; 1996 Dec; 18(6):1195-7. PubMed ID: 8971396
[TBL] [Abstract][Full Text] [Related]
4. Recurrent endobronchial diffuse large B-cell lymphoma. Diagnosed by cryoprobe.
Pajares V; Torrego A; Granell M; Szafranska J; Mozos A; Puzo C
Arch Bronconeumol; 2013 May; 49(5):210-2. PubMed ID: 22981515
[TBL] [Abstract][Full Text] [Related]
5. ESHAP chemotherapy regimen associated to lenalidomide induces complete isotopic remission in Hodgkin's lymphoma relapsing after autologous stem cell transplantation.
Tempescul A; Ianotto JC; Eveillard JR; Guillerm G; Berthou C
Ann Hematol; 2011 Aug; 90(8):971-3. PubMed ID: 21057951
[No Abstract] [Full Text] [Related]
6. High-dose infusional ifosfamide, etoposide plus methylprednisolone followed by dexamethasone, high-dose ara-C and cisplatinum and autologous stem cell transplantation for refractory or relapsed aggressive non-Hodgkin's lymphoma.
Salar A; Martino R; Perea G; Ribera JM; López-Guillermo A; Guardia R; Escoda L; Altés A; Sierra J; Montserrat E
Haematologica; 2002 Oct; 87(10):1028-35. PubMed ID: 12368156
[TBL] [Abstract][Full Text] [Related]
7. Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation.
Fetscher S; Lübbert M; Kanz L; Behringer D; Finke J; Mertelsmann R; Lange W
Bone Marrow Transplant; 1997 Mar; 19(5):527-8. PubMed ID: 9052926
[TBL] [Abstract][Full Text] [Related]
8. Diffuse bone increase uptake of gallium-67 related to cyclophosphamide and recombinant human granulocyte-colony stimulating factor (rHuG-CSF) administration.
Ruíz-Hernández G; Solano-Vercet C; Terol-Castera MJ; Rodilla Sala E; Castillo-Pallarés FJ; Balaguer-Martínez JV; Mateo-Navarro A
Nuklearmedizin; 2000 Aug; 39(5):N78-80. PubMed ID: 10984896
[No Abstract] [Full Text] [Related]
9. ESHAP + fixed dose G-CSF as autologous peripheral blood stem cell mobilization regimen in patients with relapsed or refractory diffuse large cell and Hodgkin's lymphoma: a single institution result of 127 patients.
Akhtar S; Tbakhi A; Humaidan H; El Weshi A; Rahal M; Maghfoor I
Bone Marrow Transplant; 2006 Feb; 37(3):277-82. PubMed ID: 16400345
[TBL] [Abstract][Full Text] [Related]
10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS
Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091
[TBL] [Abstract][Full Text] [Related]
12. [High-clore chemotherapy followed by autologous peripheral blood stem cell transplantation (PBSCT) for patients with malignant lymphoma--its role in the treatment strategy for non-Hodgkin's lymphoma, and ESHAP + PBSCT therapy].
Tanosaki R; Okamoto S
Rinsho Ketsueki; 1996 Jul; 37(7):591-7. PubMed ID: 8779778
[No Abstract] [Full Text] [Related]
13. Peripheral blood stem cell mobilization following salvage chemotherapy (IAPVP-16) plus granulocyte colony-stimulating factor and autografting for non-Hodgkin's lymphoma.
Martínez C; Mateu R; Sureda A; Brunet S; Amill B; Madoz P; Portos JM; Subirà M; García-López J; Domingo-Albós A
Transplant Proc; 1995 Aug; 27(4):2355-6. PubMed ID: 7544503
[No Abstract] [Full Text] [Related]
14. ESHAP chemotherapy for relapsed/refractory non-Hodgkin's lymphoma.
Sweetenham JW; Johnson PW
J Clin Oncol; 1994 Dec; 12(12):2766. PubMed ID: 7989954
[No Abstract] [Full Text] [Related]
15. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
[TBL] [Abstract][Full Text] [Related]
17. Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi).
Tarella C; Zanni M; Di Nicola M; Patti C; Calvi R; Pescarollo A; Zoli V; Fornari A; Novero D; Cabras A; Stella M; Comino A; Remotti D; Ponzoni M; Caracciolo D; Ladetto M; Magni M; Devizzi L; Rosato R; Boccadoro M; Bregni M; Corradini P; Gallamini A; Majolino I; Mirto S; Gianni AM;
Leukemia; 2007 Aug; 21(8):1802-11. PubMed ID: 17554382
[TBL] [Abstract][Full Text] [Related]
18. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma.
Philip T; Guglielmi C; Hagenbeek A; Somers R; Van der Lelie H; Bron D; Sonneveld P; Gisselbrecht C; Cahn JY; Harousseau JL
N Engl J Med; 1995 Dec; 333(23):1540-5. PubMed ID: 7477169
[TBL] [Abstract][Full Text] [Related]
19. High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin's lymphoma.
Weaver CH; Schwartzberg L; Rhinehart S; West J; Zhen B; West WH; Buckner CD
Bone Marrow Transplant; 1998 Feb; 21(4):383-9. PubMed ID: 9509973
[TBL] [Abstract][Full Text] [Related]
20. Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
Stamatoullas A; Fruchart C; Bastit D; Boulet D; Moncondult M; Piguet H; Tilly H
Cancer; 1996 Jun; 77(11):2302-7. PubMed ID: 8635099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
